A possible association between the small conductance calcium-regulated potassium channel gene, hSKCa3, and schizophrenia has recently been described by Chandy et al 1 using a case-control design with patients with schizophrenia (n = 141) and matched controls (n = 158). The gene may be considered as an excellent candidate gene for psychiatric disorders, since it plays a role in modulating neuronal firing patterns by regulating the slow component of afterhyperpolarisation. In addition, the gene contains a highly polymorphic trinucleotide sequence (CAG) within exon 1, which encodes a polyglutamine stretch. The possible contribution of unstable trinucleotide repeats to the development of psychiatric disorders has previously been discussed.
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Chandy et al 1 reported an over-representation of alleles with higher repeat number in schizophrenics as compared to controls (P = 0.0035). In an attempt to replicate these findings, we have performed a family-based study with 193 offspring/parent combinations using a sample of 49 multiplex families (two or more affected siblings with parents) and a second sample of 83 simplex families (one affected offspring with parents). No evidence for the association of longer repeats with schizophrenia was obtained when each sample was tested separately or when both samples were combined and tested for transmission disequilibrium.
Conventional linkage analysis in complex disorders like schizophrenia may fail, if the genetic component has only a modest effect on the development of the disease. It has been argued that in such cases association studies have greater power. 5 However, there are at least two requirements to be considered in the design of association studies. As it is not yet possible to study all human genes, a good candidate gene with a convincing a priori hypothesis should be available. Secondly, suitable statistical methods are required in order to avoid factors such as population admixture, heterogeneity and population stratification from confounding the results.
The hSKCa3 gene has been considered by Chandy et al 1 as a good candidate gene for schizophrenia because of the hyperpolarizing effect of the KCa channel on the membrane potential. Moreover, the N-terminal region of the hSKCa3 protein contains two tandemly arranged polyglutamine arrays encoded by two polymorphic CAG repeats. The more 3Ј repeat is highly polymorphic, with the number of CAG units ranging from 13 to 29 in Europeans of French Alsatian and German ancestry. 6 Trinucleotide repeats are considered as candidates for neuropsychiatric disorders for many reasons, [2] [3] [4] particularly as their involvement could explain the non-mendelian type of inheritance, and the phenomenon of anticipation that has been observed in schizophrenia by some authors. 7 In contrast to trinucleotide disorders such as Huntington's Chorea or myotonic dystrophy, where an abnormal length of repeats is associated with the development of the disease, Chandy et al detected an overlap of alleles between patients and controls, with an over-representation of longer alleles (Ͼ19 CAG repeats) in schizophrenic patients). This may suggest that longer alleles mediate enhanced sussceptibility to the disease, but do not necessarily alone cause the disease. Thus it is conceivable that these alleles are also detectable in unaffected individuals.
The second requirement for association studies may be fulfilled by applying the Transmission Disequilibrium Test (TDT) 8, 9 which is a family-based test that analyses the transmission of alleles from heterozygous parents to affected offsprings. A requirement for the test is the availability of a sample with one or more schizophrenic offspring together with their parents. This necessitates additional efforts in ascertainment and may be difficult because of the frequently disrupted structure of families suffering from psychiatric disorders.
Two samples were available to us, one with 49 multiplex families, each family having at least two siblings affected with schizophrenia and both parents (110 offspring/parent triads, Table 1 ), and a second one with 83 simplex families, each consisting of one offspring affected with schizophrenia, and both parents. Altogether, 193 triads were analysed for transmission disequilibrium of alleles transmitted from heterozygous parents. Both CAG repeats within the hSKCa3 gene were simultaneously amplified using PCR primers that flank the two repeats. After PstI digestion of the PCR products and electrophoretic separation, the highly polymorphic more 3Ј-repeat was evaluated. Alleles with from 11 to 23 CAG repeat units were observed. Following the report of Chandy et al 1 we analyzed the data for: (1) differences in allele frequency distribution between alleles transmitted and nontransmitted from heterozygous parents; and (2) association of longer alleles with the disease, after dichotomizing shorter and longer alleles, as suggested by Chandy et al. 1 No statistically significant difference in allele frequency distribution between transmitted and nontransmitted alleles was observed in our samples after applying the Wilcoxon signed rank test: in the sample with multiplex families P = 0.4067, in the sample with simplex families P = 0.3538, and in both samples combined P = 0.9276. Thus there was no support for a different overall frequency distribution in schizophrenics as reported by Chandy et al. 1 We also analyzed the data after dichotomizing the samples at the allele length of 19 repeats, which was found to be the modal allele length in the sample of Chandy et al. 1 Collapsing alleles 11-19 to allele number 1 and alleles 20 and higher to allele number 2 in the combined samples, resulted in 46 alleles number 2 transmitted from heterozygous parents, vs 54 nontransmitted alleles number 2 (TDT = 0.64, P = 0.424) ( Table 2 ). Thus our study provided no additional support for the association of longer repeats with the disease. The TDT was also not significant, when both samples were analyzed separately (multiplex families TDT = 0, P = 1.0; simplex families TDT = 1.45, P = 0.228). another population-based study has been published by Bowen et al, 10 which claims support for association between the polymorphic CAG repeat in the hSKCa3 gene and schizophrenia. The support was based on a slightly higher frequency of alleles Ͼ19, which reached statistical significance with a P value of 0.047. There was no statistically significant difference in the overall allele frequency distribution between their parent and control samples.
Using a large sample of 193 shizophrenics in a family-based association study, we have not been able to confirm the reported association. Whereas the TDT originally was introduced as a test for linkage in the presence of association, 8 it can also be used as a test of association if the data consist of nuclear families with a single affected child. 9 In this paper, more than one affected individual was used in the sample of multiplex families. This approach can inflate the probability of a false rejection of the null hypothesis of no association, but does not increase the probability of type II error. Hence, the use of related individuals cannot explain our failure to replicate the reported association.
There was no support in our sample either for a difference in allele frequency distribution or for an association of longer alleles with schizophrenia. As discussed by Spielman and Ewens, 9 the TDT, which we used for analysis excludes false positive association results due to population structure such as admixture, heterogeneity or stratification. These conditions can obscure conventional case control studies and make it impossible to draw valid conclusions.
We performed power calculations in order to find out whether the size of our sample is sufficient to test for the reported effect. These calculations revealed a power Ͼ99% for our sample assuming a disease prevalence of 1%, a frequency of 20% for the high risk allele and an allele-specific odds ratio of 2 as reported by Chandy et al. 1 When the high risk allele frequency was set to 10%, the power varied between 93% (dominant model) and Ͼ99% (recessive model).
If we assume the association reported by Chandy et al 1 represents a true association with the disease and is not due to population structure, what other reasons may account for our failure to replicate the reported association?
(1) The ascertainment of our sample was restricted to cases where both parents were available. This might introduce a bias against severe cases, where the chance to recruit the parents is reduced. Thus our sample may be enriched for a subtype of the disease. The presence of clinical heterogeneity is expected in psychiatric disorders. 1 may not be due to the hSKCA3 gene itself, but rather to linkage disequilibrium with a currently unidentified functional mutation nearby. Although our sample of German families, which had been ascertained in the area of Munich, Mainz and Bonn, should be geographically and genetically very close to the Alsatian population studied by Chandy et al, 1 a founder effect causing linkage disequilibrium may exist exclusively in the Alsatian population, but not in the population studied by us. Therefore, genetic heterogeneity may be another reason for the failure to replicate the original finding in our sample.
In conclusion, we report here the first family-based association analysis of the hSKCa3 gene with schizophrenia. No evidence for involvement of this gene in the development of schizophrenia could be detected.
Methods

Samples
The study was approved by the local ethics committees. All participants gave their informed consent after description and explanation of the study. Patients were interviewed using the Schedule for Affective Disorders and Schizophrenia-Lifetime Version (SADS-L) 11 and the Structured Clinical Interview for DSM-III Diagnoses-Personality Disorders (SCID-II).
12 Family members of patients were assessed for psychiatric symptoms using the Family History Research Criteria, Lifetime diagnoses based upon Research Diagnostic Criteria (RDC). Case records were evaluated by Opcrit. An independent psychiatrist reviewed the complete interview form, family history information and the medical records of each individual, without prior knowledge of the family relationship to the index patient, nor of the morbidity in the family.
The sample with multiplex families comprised 49 families with at least two affected siblings per family. Of these, 25 nuclear families were from Haar, Germany, 16 families were from Mainz, Germany, and eight families were from Israel. Six Israeli families were nonAshkenazi Jews, one family was Ashkenazi Jewish, and one family was of Arabic origin. This family sample contains 110 affected individuals comprising the core diagnoses schizophrenia or schizoaffective disorder, schizophrenic type according to the Research Diagnostic Criteria (RDC).
The sample of simplex families includes 83 triads (one sibling affected with schizophrenia and both parents) having a family history with psychiatric disorders. Sixty-six families were collected in Haar, eight in Mainz, and nine in Bonn as an independent sample for association/linkage disequilibrium using the TDT. 8 Genotyping PCR was performed on 100 ng of genomic DNA using the primers F1: 5ЈAAGTGCCCCTGTCCATCCTCT-3Ј and R1: 5Ј-GCCAAGCAAGTGGTCATTGAG-3Ј which were 5Ј-labeled with FAM, HEX or TET. The PCR was carried out in a PTC-200 Cycler (MJ Research Biozym, Hess Oldendorf, Germany) with an initial denaturation at 96°C for 4 min, 30 cycles of 96°C for 20 s, 61°C for 28 s, 72°C for 20 s and a final elongation at 72°C for 7 min. PCR products were digested using PstI without previous purification. The lengths of the restriction fragments were determined after electrophoresis in 6% denaturing polyacrylamide gel (PAGE) containing 8 M urea on an ABI 377 sequencer. Fragment lengths were measured relative to the DNA standard TAMRA 500 using the Gene Scan 2.02 and Genotyper 1.1 software from Applied Biosystems (Weiterstadt, Germany).
Statistical analysis
The Wilcoxon signed-rank test was used to compare the distributions of transmitted and non-transmitted alleles. Disequilibrium in transmission of alleles Ͼ19 repeats was analysed by TDT. 8 Power calculations assumed a population prevalence of 1% and an allelic odds ratio of 2 as reported by Chandy et al. 
